Close
Close
Treatment Database
Ac-225-4-PHenylbutyryl-His-D-Phe-Arg-Trp-Gly-Lys(eAhx-DOTA)-NH2
Trade Name not avaiable
Orphan Indication Uveal Melanoma
USA Market Approval
USA Designation Date 28-02-2019
Sponsor Modulation Therapeutics Incorporated
1 Medical Center Drive, MBRCC room 1817
Morgantown, West Virginia, 26506
More about Uveal melanoma
Free Newsletter
Related Videos
by Abidemi Uruejoma
464 views